MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager with overall responsibility for BioReference Laboratories (BRL), an OPKO Health company and the third largest clinical laboratory in the United States. Mr. Monk brings to BRL more than 20 years of operational, business strategy and technical experience.  Previously, Mr. Monk worked as Managing Director of […]

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can be safely monitored rather than undergo prostate biopsy MIAMI, March 16, 2018 (GLOBE NEWSWIRE) —  OPKO Health, Inc.(NASDAQ:OPK) today announced that data from a landmark study of the 4Kscore® test entitled, “Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel […]

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO Health company and the third largest commercial laboratory in the United States, effective immediately.  The Company has begun a search for his replacement and, in the interim, a committee of senior management will assume operational […]

MIAMI and ORLANDO, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) (“OPKO” or “the Company”), announces that BioReference Laboratories, an OPKO Health company and one of the largest commercial laboratories in the U.S., has formed a national affiliation with The Garage, a dynamic, healthcare technology change agent, to provide clinicians with advanced tools to guide quality, value-based care. BioReference Laboratories is led by pathologists […]